C57BL/6NTac-Grhl3tm1a(EUCOMM)Wtsi/IcsOrl

Status

Available to order

EMMA IDEM:07681
International strain nameC57BL/6NTac-Grhl3tm1a(EUCOMM)Wtsi/IcsOrl
Alternative nameEPD0039_3_C02
Strain typeTargeted Mutant Strains
Allele/Transgene symbolGrhl3tm1a(EUCOMM)Wtsi
Gene/Transgene symbolGrhl3
DisclaimerPlease note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
  1. We can not guarantee a null mutation for Knock-out first alleles (tm1a alleles, see http://www.mousephenotype.org/about-ikmc/targeting-strategies) as the critical exon has not been deleted.
  2. That the structure of the targeted mutation in the ES cells obtained from EUCOMM/KOMP to generate EUCOMM/KOMP mice is not verified by INFRAFRONTIER/EMMA. It is recommended that the recipient confirms the mutation structure.
  3. No check for determining the copy number of the targeting construct in ES cells obtained from EUCOMM/KOMP is done by INFRAFRONTIER/EMMA.
  4. The level of quality control before mice are released is to confirm the individual mouse genotype by short range PCR.

Information from provider

Provider ICS, Institut Clinique de la Souris
Provider affiliationICS, Institut Clinique de la Souris
Genetic informationThis mouse line originates from EUCOMM ES clone EPD0039_3_C02. For further details on the construction of this clone see the page at the IMPC portal.
Phenotypic informationPotential phenotyping data in the IMPC portal
ReferencesNone available

Information from EMMA

Archiving centreInstitut de Transgenose, INTRAGENE, Orléans, France
Animals used for archivingheterozygous C57BL/6NTac

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (allele matching)
  • increased circulating calcium level / IMPC
  • abnormal retina morphology / IMPC
  • increased startle reflex / IMPC
  • increased circulating phosphate level / IMPC
  • abnormal eye morphology / IMPC
  • decreased circulating triglyceride level / IMPC
  • decreased circulating alkaline phosphatase level / IMPC
  • abnormal locomotor activation / IMPC
  • increased circulating glucose level / IMPC
  • decreased blood urea nitrogen level / IMPC
  • increased circulating amylase level / IMPC
  • preweaning lethality, complete penetrance / IMPC
IMPC phenotypes (gene matching)
  • increased startle reflex / IMPC
  • increased circulating phosphate level / IMPC
  • increased circulating glucose level / IMPC
  • decreased circulating alkaline phosphatase level / IMPC
  • decreased blood urea nitrogen level / IMPC
  • abnormal eye morphology / IMPC
  • preweaning lethality, complete penetrance / IMPC
  • abnormal retina morphology / IMPC
  • increased circulating amylase level / IMPC
  • increased circulating calcium level / IMPC
  • decreased circulating triglyceride level / IMPC
  • abnormal locomotor activation / IMPC
MGI phenotypes (gene matching)
  • cleft palate / MGI
  • abnormal vertebrae morphology / MGI
  • kyphosis / MGI
  • gastrointestinal hemorrhage / MGI
  • abnormal stomach epithelium morphology / MGI
  • abnormal intestine morphology / MGI
  • kinked tail / MGI
  • abnormal brain development / MGI
  • exencephaly / MGI
  • open neural tube / MGI
  • scaly skin / MGI
  • skin lesions / MGI
  • abnormal epidermal layer morphology / MGI
  • thick epidermis / MGI
  • epidermal hyperplasia / MGI
  • abnormal epidermis stratum basale morphology / MGI
  • abnormal epidermis stratum granulosum morphology / MGI
  • abnormal epidermis stratum corneum morphology / MGI
  • eyelids open at birth / MGI
  • excessive scratching / MGI
  • abnormal lipid level / MGI
  • decreased embryo size / MGI
  • abnormal dorsal-ventral axis patterning / MGI
  • anencephaly / MGI
  • neoplasm / MGI
  • abnormal neural tube morphology / MGI
  • no abnormal phenotype detected / MGI
  • delayed neural tube closure / MGI
  • abnormal keratinocyte differentiation / MGI
  • impaired skin barrier function / MGI
  • curly tail / MGI
  • spina bifida / MGI
  • abnormal neural tube closure / MGI
  • abnormal craniofacial development / MGI
  • fetal growth retardation / MGI
  • abnormal vertebral spinous process morphology / MGI
  • absent vertebral arch / MGI
  • split vertebrae / MGI
  • thick epidermis stratum spinosum / MGI
  • increased keratinocyte proliferation / MGI
  • abnormal corneocyte envelope morphology / MGI
  • abnormal palate development / MGI
  • perinatal lethality, complete penetrance / MGI
  • preweaning lethality, complete penetrance / MGI
  • lethality during fetal growth through weaning, complete penetrance / MGI
  • spina bifida cystica / MGI
  • abnormal periderm development / MGI
  • abnormal corneocyte morphology / MGI

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).